Aligos Therapeutics

ALGS · NASDAQ

$5.03+$0.19 (+3.93%)TodayMarket closed ·
Prev close $4.84

Who owns ALGS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 39.9% of ALGS’s shares.

  • Deep Track Capital LP7.2%
  • Roche Holding AG7.1%
  • Alyeska Investment Group, L.P.6.7%
  • Sio Capital Management, LLC5.3%
  • Next 6 largest institutions13.7%
  • All other shareholders60.1%
Top institutional holders of ALGS
HolderShares% of shares
Deep Track Capital LP444.11K7.17%
Roche Holding AG441.04K7.12%
Alyeska Investment Group, L.P.412.00K6.66%
Sio Capital Management, LLC327.24K5.29%
Marshall Wace LLP246.58K3.98%
Woodline Partners LP177.36K2.87%
Vanguard Capital Management, LLC175.54K2.84%
Blatt (Lawrence M)88.42K1.43%
Baker Bros. Advisors LP83.06K1.34%
HHLR Advisors, Ltd.76.25K1.23%

Largest mutual fund holders

Top mutual fund holders of ALGS
HolderShares% of shares
Vanguard Total Stock Market Index Fund128.77K2.08%
Vanguard Extended Market Index Fund46.77K0.76%
Fidelity Extended Market Index Fund22.12K0.36%
iShares Micro-Cap ETF16.64K0.27%
Fidelity Total Market Index Fund7.55K0.12%

Short interest

Settled Sep 30, 2026

Shares short
708.74K
Days to cover
14.35
% of shares outstanding
11.45%
Average daily volume
49.39K
Change since last report
+1.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.